Penserra Capital Management’s Core Laboratories CLB Stock Holding History

Penserra Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-576	Closed	-$30K	–	868
2019 Q2	$30K	Buy	576 +51	+10%	+$2.99K	﹤0.01%	709
2019 Q1	$36K	Sell	525 -35	-6%	-$2.35K	﹤0.01%	590
2018 Q4	$33K	Sell	560 -210	-27%	-$18.1K	﹤0.01%	504
2018 Q3	$89K	Buy	770 +110	+17%	+$12.4K	0.01%	457
2018 Q2	$83K	Sell	660 -80	-11%	-$9.74K	0.01%	389
2018 Q1	$88K	Buy	+740	New	+$81.9K	0.01%	312

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Penserra Capital Management's CLB Position: Q3 2019 in Review

Penserra Capital Management sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 576 shares — an estimated $30K sold.

Penserra Capital Management first reported a position in CLB in Q1 2018 and held it in 6 quarters. The position peaked at $89K in Q3 2018. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Penserra Capital Management reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
Penserra Capital Management sold 576 Core Laboratories shares in Q3 2019, an estimated $30K.
Penserra Capital Management first reported a position in Core Laboratories in Q1 2018 and held it in 6 quarters.
Penserra Capital Management's Core Laboratories position peaked at $89K in Q3 2018.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Penserra Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.